Loading…

Effect of melatonin on hyperlipidemic nephropathy under constant light exposure

Studies have shown anti-hyperlipidemic actions of melatonin, with pharmacological doses inducing changes in cholesterol levels. This study was designed to evaluate the effect of melatonin on adriamycin-induced (25mg/kg b.w., i.p.) hyperlipidemia under constant light exposure. Melatonin was injected...

Full description

Saved in:
Bibliographic Details
Published in:Journal of physiology and biochemistry 2002-06, Vol.58 (2), p.109-114
Main Authors: Túnez, L, Muñoz, M C, Feijoo-López, A L, Valdvira, E, Bujalance-Arenas, L, Montilla, P
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c283t-ab7e081210d2376444f64b746aa12ad955d15f6680434bce2a6391bd84271ee13
cites cdi_FETCH-LOGICAL-c283t-ab7e081210d2376444f64b746aa12ad955d15f6680434bce2a6391bd84271ee13
container_end_page 114
container_issue 2
container_start_page 109
container_title Journal of physiology and biochemistry
container_volume 58
creator Túnez, L
Muñoz, M C
Feijoo-López, A L
Valdvira, E
Bujalance-Arenas, L
Montilla, P
description Studies have shown anti-hyperlipidemic actions of melatonin, with pharmacological doses inducing changes in cholesterol levels. This study was designed to evaluate the effect of melatonin on adriamycin-induced (25mg/kg b.w., i.p.) hyperlipidemia under constant light exposure. Melatonin was injected i.p. (1,000 microg/kg b.w./day). Triglycerides, total cholesterol, high-density lipoprotein cholesterol, light-density lipoprotein cholesterol, non-proteic nitrogen compounds (urea and creatinine levels), total protein in serum, proteins eliminated in the urine and melatonin levels in serum and kidney were determined. Results show a decrease in melatonin levels induced by both adriamycin and constant light. Likewise, adriamycin induced significant increases in triglycerides, total cholesterol and light-density lipoprotein cholesterol, and lowered high-density lipoprotein cholesterol levels. Constant light exposure also prompted an increase in LDL-c levels and a decrease in HDL-c values, and intensified the effects of adriamycin on these two lipoproteins. All changes induced by adriamycin and constant light were reverted toward normality by melatonin administration.
doi_str_mv 10.1007/BF03179846
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF03179846</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>12435086</sourcerecordid><originalsourceid>FETCH-LOGICAL-c283t-ab7e081210d2376444f64b746aa12ad955d15f6680434bce2a6391bd84271ee13</originalsourceid><addsrcrecordid>eNpFkEFLwzAYhoMobk4v_gDJWajmS9IkO-rYVBjsoueStl9tpU1DkoL790422Ol9Dw_P4SHkHtgTMKafXzdMgF4aqS7IHIzWmdF5fnn4IEymc2lm5CbGH8YkB86uyQy4FDkzak5266bBKtGxoQP2No2uc3R0tN17DH3nuxqHrqIOfRtGb1O7p5OrMdBqdDFZl2jffbeJ4q8f4xTwllw1to94d9oF-dqsP1fv2Xb39rF62WYVNyJlttTIDHBgNRdaSSkbJUstlbXAbb3M8xryRinDpJBlhdwqsYSyNpJrQASxII9HbxXGGAM2hQ_dYMO-AFb8VynOVQ7wwxH2UzlgfUZPGcQf6LNcww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effect of melatonin on hyperlipidemic nephropathy under constant light exposure</title><source>Springer Link</source><creator>Túnez, L ; Muñoz, M C ; Feijoo-López, A L ; Valdvira, E ; Bujalance-Arenas, L ; Montilla, P</creator><creatorcontrib>Túnez, L ; Muñoz, M C ; Feijoo-López, A L ; Valdvira, E ; Bujalance-Arenas, L ; Montilla, P</creatorcontrib><description>Studies have shown anti-hyperlipidemic actions of melatonin, with pharmacological doses inducing changes in cholesterol levels. This study was designed to evaluate the effect of melatonin on adriamycin-induced (25mg/kg b.w., i.p.) hyperlipidemia under constant light exposure. Melatonin was injected i.p. (1,000 microg/kg b.w./day). Triglycerides, total cholesterol, high-density lipoprotein cholesterol, light-density lipoprotein cholesterol, non-proteic nitrogen compounds (urea and creatinine levels), total protein in serum, proteins eliminated in the urine and melatonin levels in serum and kidney were determined. Results show a decrease in melatonin levels induced by both adriamycin and constant light. Likewise, adriamycin induced significant increases in triglycerides, total cholesterol and light-density lipoprotein cholesterol, and lowered high-density lipoprotein cholesterol levels. Constant light exposure also prompted an increase in LDL-c levels and a decrease in HDL-c values, and intensified the effects of adriamycin on these two lipoproteins. All changes induced by adriamycin and constant light were reverted toward normality by melatonin administration.</description><identifier>ISSN: 1138-7548</identifier><identifier>EISSN: 1877-8755</identifier><identifier>DOI: 10.1007/BF03179846</identifier><identifier>PMID: 12435086</identifier><language>eng</language><publisher>Spain</publisher><subject>Animals ; Cholesterol - blood ; Creatinine - blood ; Doxorubicin - adverse effects ; Hyperlipidemias - blood ; Hyperlipidemias - chemically induced ; Hyperlipidemias - metabolism ; Kidney - drug effects ; Kidney - metabolism ; Kidney Diseases - blood ; Kidney Diseases - chemically induced ; Kidney Diseases - metabolism ; Light ; Lipoproteins, HDL - blood ; Lipoproteins, HDL - classification ; Lipoproteins, LDL - blood ; Lipoproteins, LDL - classification ; Male ; Melatonin - metabolism ; Melatonin - pharmacology ; Proteinuria - chemically induced ; Proteinuria - metabolism ; Rats ; Rats, Wistar ; Triglycerides - blood ; Urea - blood</subject><ispartof>Journal of physiology and biochemistry, 2002-06, Vol.58 (2), p.109-114</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c283t-ab7e081210d2376444f64b746aa12ad955d15f6680434bce2a6391bd84271ee13</citedby><cites>FETCH-LOGICAL-c283t-ab7e081210d2376444f64b746aa12ad955d15f6680434bce2a6391bd84271ee13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12435086$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Túnez, L</creatorcontrib><creatorcontrib>Muñoz, M C</creatorcontrib><creatorcontrib>Feijoo-López, A L</creatorcontrib><creatorcontrib>Valdvira, E</creatorcontrib><creatorcontrib>Bujalance-Arenas, L</creatorcontrib><creatorcontrib>Montilla, P</creatorcontrib><title>Effect of melatonin on hyperlipidemic nephropathy under constant light exposure</title><title>Journal of physiology and biochemistry</title><addtitle>J Physiol Biochem</addtitle><description>Studies have shown anti-hyperlipidemic actions of melatonin, with pharmacological doses inducing changes in cholesterol levels. This study was designed to evaluate the effect of melatonin on adriamycin-induced (25mg/kg b.w., i.p.) hyperlipidemia under constant light exposure. Melatonin was injected i.p. (1,000 microg/kg b.w./day). Triglycerides, total cholesterol, high-density lipoprotein cholesterol, light-density lipoprotein cholesterol, non-proteic nitrogen compounds (urea and creatinine levels), total protein in serum, proteins eliminated in the urine and melatonin levels in serum and kidney were determined. Results show a decrease in melatonin levels induced by both adriamycin and constant light. Likewise, adriamycin induced significant increases in triglycerides, total cholesterol and light-density lipoprotein cholesterol, and lowered high-density lipoprotein cholesterol levels. Constant light exposure also prompted an increase in LDL-c levels and a decrease in HDL-c values, and intensified the effects of adriamycin on these two lipoproteins. All changes induced by adriamycin and constant light were reverted toward normality by melatonin administration.</description><subject>Animals</subject><subject>Cholesterol - blood</subject><subject>Creatinine - blood</subject><subject>Doxorubicin - adverse effects</subject><subject>Hyperlipidemias - blood</subject><subject>Hyperlipidemias - chemically induced</subject><subject>Hyperlipidemias - metabolism</subject><subject>Kidney - drug effects</subject><subject>Kidney - metabolism</subject><subject>Kidney Diseases - blood</subject><subject>Kidney Diseases - chemically induced</subject><subject>Kidney Diseases - metabolism</subject><subject>Light</subject><subject>Lipoproteins, HDL - blood</subject><subject>Lipoproteins, HDL - classification</subject><subject>Lipoproteins, LDL - blood</subject><subject>Lipoproteins, LDL - classification</subject><subject>Male</subject><subject>Melatonin - metabolism</subject><subject>Melatonin - pharmacology</subject><subject>Proteinuria - chemically induced</subject><subject>Proteinuria - metabolism</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Triglycerides - blood</subject><subject>Urea - blood</subject><issn>1138-7548</issn><issn>1877-8755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNpFkEFLwzAYhoMobk4v_gDJWajmS9IkO-rYVBjsoueStl9tpU1DkoL790422Ol9Dw_P4SHkHtgTMKafXzdMgF4aqS7IHIzWmdF5fnn4IEymc2lm5CbGH8YkB86uyQy4FDkzak5266bBKtGxoQP2No2uc3R0tN17DH3nuxqHrqIOfRtGb1O7p5OrMdBqdDFZl2jffbeJ4q8f4xTwllw1to94d9oF-dqsP1fv2Xb39rF62WYVNyJlttTIDHBgNRdaSSkbJUstlbXAbb3M8xryRinDpJBlhdwqsYSyNpJrQASxII9HbxXGGAM2hQ_dYMO-AFb8VynOVQ7wwxH2UzlgfUZPGcQf6LNcww</recordid><startdate>20020601</startdate><enddate>20020601</enddate><creator>Túnez, L</creator><creator>Muñoz, M C</creator><creator>Feijoo-López, A L</creator><creator>Valdvira, E</creator><creator>Bujalance-Arenas, L</creator><creator>Montilla, P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20020601</creationdate><title>Effect of melatonin on hyperlipidemic nephropathy under constant light exposure</title><author>Túnez, L ; Muñoz, M C ; Feijoo-López, A L ; Valdvira, E ; Bujalance-Arenas, L ; Montilla, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c283t-ab7e081210d2376444f64b746aa12ad955d15f6680434bce2a6391bd84271ee13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Cholesterol - blood</topic><topic>Creatinine - blood</topic><topic>Doxorubicin - adverse effects</topic><topic>Hyperlipidemias - blood</topic><topic>Hyperlipidemias - chemically induced</topic><topic>Hyperlipidemias - metabolism</topic><topic>Kidney - drug effects</topic><topic>Kidney - metabolism</topic><topic>Kidney Diseases - blood</topic><topic>Kidney Diseases - chemically induced</topic><topic>Kidney Diseases - metabolism</topic><topic>Light</topic><topic>Lipoproteins, HDL - blood</topic><topic>Lipoproteins, HDL - classification</topic><topic>Lipoproteins, LDL - blood</topic><topic>Lipoproteins, LDL - classification</topic><topic>Male</topic><topic>Melatonin - metabolism</topic><topic>Melatonin - pharmacology</topic><topic>Proteinuria - chemically induced</topic><topic>Proteinuria - metabolism</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Triglycerides - blood</topic><topic>Urea - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Túnez, L</creatorcontrib><creatorcontrib>Muñoz, M C</creatorcontrib><creatorcontrib>Feijoo-López, A L</creatorcontrib><creatorcontrib>Valdvira, E</creatorcontrib><creatorcontrib>Bujalance-Arenas, L</creatorcontrib><creatorcontrib>Montilla, P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of physiology and biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Túnez, L</au><au>Muñoz, M C</au><au>Feijoo-López, A L</au><au>Valdvira, E</au><au>Bujalance-Arenas, L</au><au>Montilla, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of melatonin on hyperlipidemic nephropathy under constant light exposure</atitle><jtitle>Journal of physiology and biochemistry</jtitle><addtitle>J Physiol Biochem</addtitle><date>2002-06-01</date><risdate>2002</risdate><volume>58</volume><issue>2</issue><spage>109</spage><epage>114</epage><pages>109-114</pages><issn>1138-7548</issn><eissn>1877-8755</eissn><abstract>Studies have shown anti-hyperlipidemic actions of melatonin, with pharmacological doses inducing changes in cholesterol levels. This study was designed to evaluate the effect of melatonin on adriamycin-induced (25mg/kg b.w., i.p.) hyperlipidemia under constant light exposure. Melatonin was injected i.p. (1,000 microg/kg b.w./day). Triglycerides, total cholesterol, high-density lipoprotein cholesterol, light-density lipoprotein cholesterol, non-proteic nitrogen compounds (urea and creatinine levels), total protein in serum, proteins eliminated in the urine and melatonin levels in serum and kidney were determined. Results show a decrease in melatonin levels induced by both adriamycin and constant light. Likewise, adriamycin induced significant increases in triglycerides, total cholesterol and light-density lipoprotein cholesterol, and lowered high-density lipoprotein cholesterol levels. Constant light exposure also prompted an increase in LDL-c levels and a decrease in HDL-c values, and intensified the effects of adriamycin on these two lipoproteins. All changes induced by adriamycin and constant light were reverted toward normality by melatonin administration.</abstract><cop>Spain</cop><pmid>12435086</pmid><doi>10.1007/BF03179846</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1138-7548
ispartof Journal of physiology and biochemistry, 2002-06, Vol.58 (2), p.109-114
issn 1138-7548
1877-8755
language eng
recordid cdi_crossref_primary_10_1007_BF03179846
source Springer Link
subjects Animals
Cholesterol - blood
Creatinine - blood
Doxorubicin - adverse effects
Hyperlipidemias - blood
Hyperlipidemias - chemically induced
Hyperlipidemias - metabolism
Kidney - drug effects
Kidney - metabolism
Kidney Diseases - blood
Kidney Diseases - chemically induced
Kidney Diseases - metabolism
Light
Lipoproteins, HDL - blood
Lipoproteins, HDL - classification
Lipoproteins, LDL - blood
Lipoproteins, LDL - classification
Male
Melatonin - metabolism
Melatonin - pharmacology
Proteinuria - chemically induced
Proteinuria - metabolism
Rats
Rats, Wistar
Triglycerides - blood
Urea - blood
title Effect of melatonin on hyperlipidemic nephropathy under constant light exposure
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T23%3A16%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20melatonin%20on%20hyperlipidemic%20nephropathy%20under%20constant%20light%20exposure&rft.jtitle=Journal%20of%20physiology%20and%20biochemistry&rft.au=T%C3%BAnez,%20L&rft.date=2002-06-01&rft.volume=58&rft.issue=2&rft.spage=109&rft.epage=114&rft.pages=109-114&rft.issn=1138-7548&rft.eissn=1877-8755&rft_id=info:doi/10.1007/BF03179846&rft_dat=%3Cpubmed_cross%3E12435086%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c283t-ab7e081210d2376444f64b746aa12ad955d15f6680434bce2a6391bd84271ee13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/12435086&rfr_iscdi=true